Influenza 2013: Epidemiology, Vaccines and Threats
Symposium - New York City, United States
Influenza continues to confound us with the continual evolution of the virus and emergence of new influenza viruses from the animal reservoir. Vaccines have been improved to broaden response with quadrivalent vaccines, low efficacy has been addressed with increased antigen content in vaccines. A new vaccine which contains only the main surface antigen has been approved by the FDA. Synthetic vaccines are being developed in plant systems.
Organization: New York Academy of Sciences
(Courtesy of Influenza virus, via en.wikipedia.org)
Influenza 2013: Epidemiology, Vaccines and Threats
14th November 2013 at 12:00pm to 4:00pm (GMT-05:00) Eastern Time (US & Canada)
New York Academy of Sciences, 250 Greenwich Street, 40th Floor, New York City, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.